Takahisa Mikami

Neurology

399 Revolution Dr
Suite 580
Somerville, MA 02145

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

CD4+ T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

CD4+ T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

Journal: Science translational medicine

Published: July 15, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2026

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 11, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 04, 2026

Early Relapse Risk in Biopsy-Confirmed Primary Central Nervous System Vasculitis.

Early Relapse Risk in Biopsy-Confirmed Primary Central Nervous System Vasculitis.

Journal: JAMA neurology

Published: January 05, 2026

Lack of external validity of the MOG-AR score in a North American cohort.

Lack of external validity of the MOG-AR score in a North American cohort.

Journal: Multiple sclerosis and related disorders

Published: November 05, 2025

Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation.

Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation.

Journal: Multiple sclerosis and related disorders

Published: October 19, 2025

A Threshold in Anti-EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders.

A Threshold in Anti-EBNA-1 Antibody Titers Distinguishes Salivary EBV Shedders From Nonshedders.

Journal: The Journal of infectious diseases

Published: October 10, 2025

Neuropsychologic impact of MOGAD: A patient reported outcomes study.

Neuropsychologic impact of MOGAD: A patient reported outcomes study.

Journal: Multiple sclerosis and related disorders

Published: May 22, 2025

Relapse risk factors in double seronegative neuromyelitis optica spectrum disorder: Insights from a multicenter study.

Relapse risk factors in double seronegative neuromyelitis optica spectrum disorder: Insights from a multicenter study.

Journal: Multiple sclerosis and related disorders

Published: March 25, 2025

CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation.

CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 21, 2024

Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves.

Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves.

Journal: JAMA cardiology

Published: May 22, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026